Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity-Reference-Cited by-同舟云学术

Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity

Published:2023-10 Issue: Volume:336 Page:199214
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Rahni Zeynab,Hosseini Seyed Masoud,Shahrokh Shabnam,Saeedi Niasar Mahsa,Shoraka Shahrzad,Mirjalali Hamed,Nazemalhosseini-Mojarad Ehsan,Rostami-Nejad Mohammad,Malekpour Habib,Zali Mohammad Reza,Mohebbi Seyed Reza

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference88 articles.

1. The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease;Abbasi-Kolli;Braz. J. Infect. Dis.,2022

2. Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways;Amini-Farsani;Int. Immunopharmacol.,2021

3. Age-severity matched cytokine profiling reveals specific signatures in COVID-19 patients;Angioni;Cell Death Dis.,2020

4. Post-translation modification of proteins; methodologies and applications in plant sciences;Bond;Phytochemistry,2011

5. Novel human lncRNA–disease association inference based on lncRNA expression profiles;Chen;Bioinformatics,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal Non-coding RNA Derived from Mesenchymal Stem Cells (MSCs) in Autoimmune Diseases Progression and Therapy; an Updated Review;Cell Biochemistry and Biophysics;2024-09-03

2. Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks;Infection, Genetics and Evolution;2024-08

3. lncRNA Biomarkers of Glioblastoma Multiforme;Biomedicines;2024-04-23

4. SARS-CoV-2 and chronic hepatitis B: Focusing on the possible consequences of co-infection;Journal of Clinical Virology Plus;2023-11